CIA
TMO icon

CCM Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History

CCM Investment Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
28,029
+845
+3% +$406K 1.09% 42
2026
Q1 		$13.4M Sell
27,184
-540
-2% -$293K 1.28% 39
2025
Q4 		$16.1M Sell
27,724
-2,163
-7% -$1.22M 1.54% 29
2025
Q3 		$14.5M Sell
29,887
-1,457
-5% -$678K 1.43% 30
2025
Q2 		$12.7M Buy
31,344
+449
+1% +$188K 1.37% 38
2025
Q1 		$15.4M Sell
30,895
-1,026
-3% -$556K 1.89% 22
2024
Q4 		$16.6M Buy
31,921
+2,822
+10% +$1.55M 1.84% 19
2024
Q3 		$18M Buy
29,099
+60
+0.2% +$35.5K 2.01% 16
2024
Q2 		$16.1M Buy
29,039
+169
+0.6% +$96.8K 1.89% 17
2024
Q1 		$16.8M Sell
28,870
-692
-2% -$388K 2.01% 16
2023
Q4 		$15.7M Buy
29,562
+1,050
+4% +$508K 1.93% 18
2023
Q3 		$14.4M Buy
28,512
+998
+4% +$532K 1.99% 16
2023
Q2 		$14.4M Buy
27,514
+1,450
+6% +$782K 1.93% 19
2023
Q1 		$15M Buy
26,064
+2,244
+9% +$1.26M 2.13% 12
2022
Q4 		$13.1M Sell
23,820
-893
-4% -$473K 2.08% 20
2022
Q3 		$12.5M Sell
24,713
-453
-2% -$254K 2.13% 13
2022
Q2 		$13.7M Sell
25,166
-143
-0.6% -$78.7K 2.2% 10
2022
Q1 		$14.9M Sell
25,309
-1,957
-7% -$1.12M 2.04% 13
2021
Q4 		$18.2M Sell
27,266
-1,437
-5% -$897K 2.21% 8
2021
Q3 		$16.4M Sell
28,703
-258
-0.9% -$142K 2.13% 7
2021
Q2 		$14.6M Sell
28,961
-28
-0.1% -$13.2K 1.87% 16
2021
Q1 		$13.2M Sell
28,989
-1,048
-3% -$500K 1.79% 24
2020
Q4 		$14M Sell
30,037
-1,517
-5% -$711K 2.03% 14
2020
Q3 		$13.9M Sell
31,554
-3,243
-9% -$1.34M 2.26% 8
2020
Q2 		$12.6M Sell
34,797
-1,076
-3% -$361K 2.15% 11
2020
Q1 		$10.2M Sell
35,873
-3,520
-9% -$1.11M 2.03% 19
2019
Q4 		$12.8M Sell
39,393
-837
-2% -$254K 1.99% 17
2019
Q3 		$11.7M Buy
40,230
+1,159
+3% +$332K 1.92% 21
2019
Q2 		$11.5M Buy
39,071
+5,546
+17% +$1.53M 1.93% 21
2019
Q1 		$9.18M Buy
+33,525
New +$8.34M 1.54% 37

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

CCM Investment Advisers's TMO Position: Q2 2026 in Review

CCM Investment Advisers increased its Thermo Fisher Scientific (TMO) stake by 3.1% in Q2 2026, buying an estimated $406K and bringing the position to 28,029 shares worth $14.1M. The position accounts for 1.09% of the portfolio, ranked #42.

CCM Investment Advisers first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $18.2M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CCM Investment Advisers held 28,029 shares of Thermo Fisher Scientific worth $14.1M as of Q2 2026.
  • CCM Investment Advisers bought 845 Thermo Fisher Scientific shares in Q2 2026, an estimated $406K.
  • Thermo Fisher Scientific made up 1.09% of CCM Investment Advisers's portfolio in Q2 2026, its #42 holding.
  • CCM Investment Advisers first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • CCM Investment Advisers's Thermo Fisher Scientific position peaked at $18.2M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CCM Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.